Improving muscle health

Nathan K. LeBrasseur, M.S., Ph.D., associate professor and co-chair of research in the Department of Physical Medicine and Rehabilitation, Mayo Clinic College of Medicine, discusses age- and disease-associated muscle loss.

Gene therapy for neuromuscular diseases: Surprising lessons learned from dogs

Martin Childers, D.O., Ph.D., is joined by Carmen M. Terzic, M.D., Ph.D., to discuss his gene therapy work.

Age-related muscle loss

Nathan K. LeBrasseur, M.S., Ph.D., discusses research at the Robert and Arlene Kogod Center on Aging with Carmen M. Terzic, M.D., Ph.D., chair of Physical Medicine and Rehabilitation, at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.

Gene therapy for cartilage regeneration

Christopher H. Evans, Ph.D., and Carmen M. Terzic, M.D., Ph.D., discuss gene therapy for cartilage regeneration at the 2015 Fourth Annual Symposium on Regenerative Rehabilitation.

International Consortium for Regenerative Rehabilitation

Fabrisia Ambrosio, Ph.D., M.P.T., and Carmen M. Terzic, M.D., Ph.D., discuss the formation of the International Consortium for Regenerative Rehabilitation.

Strengthening the HLHS heart with regenerative medicine

Regenerative medicine — the ability to bioengineer and make new heart muscle and apply it to patients with weak hearts — is changing the future for children with hypoplastic left heart syndrome.

Regenerating heart tissue through stem cell therapy

Andre Terzic, M.D., Ph.D., director of the Center for Regenerative Medicine, and Atta Behfar, M.D., Ph.D., director of the center's Cardiac Regeneration Program, discuss the ways that stem cells are transforming health care.

Mayo Clinic scientists propose a breast cancer drug for bladder cancer patients

Amplification of HER2, a known driver of some breast cancers, in a type of bladder cancer called micropapillary urothelial carcinoma (MPUC), has shown that the presence of HER2 amplification is associated with particularly aggressive tumors.

Emergency treatment longer for heart attack victims arriving at hospital during off-hours

Atsushi Sorita, M.D., a senior fellow in preventive medicine at Mayo Clinic, describes a study that found more people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours.

Zebrafish Discovery May Shed Light on Human Kidney Function

Researchers say the discovery of how sodium ions pass through the gill of a zebrafish may be a clue to understanding a key function in the human kidney. The findings from a collaboration between Mayo Clinic and the Tokyo Institute of Technology ...

Mayo Clinic Discovers African-Americans Respond Better to Rubella Vaccine

Somali Americans develop twice the antibody response to rubella from the current vaccine compared to Caucasians.

Grand Rounds: Cardiac Regeneration

Atta Behfar, M.D., Ph.D., presents Cardiac Regeneration.

Mayo Clinic first in U.S. testing stem cell use in pediatric congenital heart disease trial

Mayo Clinic is announcing the first stem cell clinical trial for pediatric congenital heart disease in the U.S. The trial aims to determine how stem cells from autologous umbilical cord blood can help children with hypoplastic left heart syndrome (HLHS).

Stem cells get hip

Stem cells are the starting point for all the tissues in your body. Your body grows them all the time. So, Mayo researchers thought why not put them to work healing damaged tissues such as heart muscle or bone.

Regenerative Medicine: Mayo Clinic and Collaborators Develop New Tool for Transplanting Stem Cells

Mayo Clinic researchers and colleagues in Belgium have developed a specialized catheter for transplanting stem cells into the beating heart.